Biotech | April 18, 2026
Department of Biotechnology invites applications for DBT Research Associateship 2025–26
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
The new capital is expected to fund the company through 2029
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
The NDA filing is supported by results from the phase III evERA Breast Cancer study
The initiative, delivered in collaboration with Accenture, integrates digitally enabled operating models powered by advanced analytics and AI across the company’s procurement, manufacturing, and distribution networks
The FDA’s Center for Biologics Evaluation and Research (CBER) cited Moderna’s choice of a licensed standard-dose flu vaccine as the comparator in its Phase 3 trial, saying it “does not reflect the best-available standard of care.”
Subscribe To Our Newsletter & Stay Updated
